Showing 254 news articles about Pregnancy and vertical transmission

Filters Content type: News Topic: Pregnancy and vertical transmission

Information about the use of antiretroviral drugs in pregnancy and other aspects of care for HIV-positive women during pregnancy, so as to prevent vertical transmission and ensure the best outcomes for both mother and infant.

Improving HIV care

Getting the most prevention and care out of programmes for the prevention of mother-to-child transmission

News
14 July 2006
Pregnancy and vertical transmission

Nevirapine-based triple-drug combinations safe for use in pregnant African women

News
10 July 2006
Improving HIV care

Revised 2005 WHO guidelines on prevention of mother-to-child transmission

News
20 September 2005
Infant feeding

Safer infant feeding

News
8 September 2005
Pregnancy and vertical transmission

Nelfinavir and nevirapine well tolerated during pregnancy

News
9 May 2005
HIV treatment

Rethinking nevirapine revisited

News
13 September 2004
Pregnancy and vertical transmission

Cumulative time on HAART increases health risks to both mother and foetus

News
15 July 2004
Pregnancy and vertical transmission

Risk of severe liver toxicities if nevirapine used in HAART in pregnant women with CD4 above 250

News
21 June 2004
Infant feeding

Breastfeeding and HIV transmission

News
11 June 2004
Pregnancy and vertical transmission

HIV-positive women less likely to become pregnant and more likely to miscarry even if asymptomatic

News
5 April 2004
Pregnancy and vertical transmission

Rapid HIV tests should be used on women in labour

News
28 January 2004
Pregnancy and vertical transmission

MTCT-plus: Family-focused care and treatment

News
9 October 2003
Pregnancy and vertical transmission

Preventing mother-to-child transmission of HIV

News
7 August 2003
Pregnancy, children & young people

Timing of nevirapine for newborns: extra syrup for baby if mother late to dose

News
6 June 2003